Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.

Norman Wolmark

NRG Oncology Network Group Operations Center

Liver and intrahepatic bile ducts

Radiation Oncology Surgery / Surgical oncology

Jian-Min Yuan

Prospective Studies of Cancer Etiology and Prevention in Shanghai and Singapore

Liver and intrahepatic bile ducts

Pathology

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Liver and intrahepatic bile ducts

Pamela Hoodless

Epigenetic Modifications Regulating Hepatocellular Carcinoma and Hepatocyte Differentiation

Liver and intrahepatic bile ducts

Carol Prives

Properties and Regulation of p53 in Tumor Cells

Liver and intrahepatic bile ducts Leukaemia

Pathology

Dean W Felsher

Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death

Sarcoma Liver and intrahepatic bile ducts Leukaemia

Christian Abnet

Case-control Study of Esophageal Squamous Cell Carcinoma (GEMINI)

Stomach Oesophagus Liver and intrahepatic bile ducts

Pathology

Ahmed Kaseb

Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepateocellular Carcinoma

Liver and intrahepatic bile ducts

Pathology

Joseph Avruch

Decoding the MST1 and MST2 Kinases in Cellular Physiology and Tumor Suppression

Liver and intrahepatic bile ducts

Pathology